Increased endothelial monocyte adhesiveness is related to clinical outcomes in chronic heart failure

International Journal of Cardiology

Volumn 121, Issue 3, 2007, Pages 276-283

  Yin, Wei Hsian ^a,c   Chen, Jaw Wen ^b,c   Shing Young, Mason ^a   Lin, Shing Jong ^b,c  

^a CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cell adhesion molecules; Chronic heart failure; Endothelial monocyte adhesiveness; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELL ADHESION MOLECULE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AORTA; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL ISOLATION; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEMODYNAMICS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; AORTA; CELL ADHESION MOLECULES; CELLS, CULTURED; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; P-SELECTIN; PROGNOSIS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR RESISTANCE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34548818129     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.012     Document Type: Article

References (28)

1. Seta Y., Shan K., Bozdurt B., Oral H., and Mann D.L. Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail 2 (1996) 243-249
2. Mann D.L. Activation of inflammatory mediators in heart failure. In: Mann D.L. (Ed). Ed. Heart Failure: A Companion to Braunwald's Heart Disease. 1st ed. (2004), Saunders, Philadelphia 159-180
3. Hasper D., Hummel M., Kleber F.X., Reindl I., and Volk H.D. Systemic inflammation in patients with heart failure. Eur Heart J 19 (1998) 761-765
4. Sharma R., Coats A.J.S., and Anker S.D. The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1. Int J Cardiol 72 (2000) 175-186
5. Yin W.H., Chen J.W., Jen H.L., et al. The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure. Eur J Heart Fail 5 (2003) 507-516
6. Tsutamoto T., Hisanaga T., Fukai D., et al. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. Am J Cardiol 76 (1995) 803-808
7. Andreassen A.K., Nordoy I., Simonsen S., et al. Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation. Am J Cardiol 81 (1998) 604-608
8. Devaux B., Scholz D., Hirche A., Klovekorn W.P., and Schaper J. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur Heart J 18 (1997) 470-479
9. Tousoulis D., Homaei H., Ahmed N., et al. Increased plasma adhesion molecules in patients with heart failure who suffered from ischemic and dilated cardiomyopathy. Am Heart J 141 (2001) 277-280
10. Yin W.H., Jen H.L., Chiang M.C., Huang W.P., Feng A.N., and Young M.S. Circulating soluble tumor necrosis factor-α and cell adhesion molecules in patients with acute cardiogenic pulmonary edema. J Emerg Crit Care Med 15 (2004) 9-19
11. McGill S.N., Ahmed N.A., and Christou N.V. Endothelial cells: role in infection and inflammation. World J Surg 22 (1998) 171-178
12. Carlos T.M., and Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood 84 (1994) 2068-2101
13. Wilhelmi M.H., Leyh R.G., Wilhelmi M., and Haverich A. Upregulation of endothelial adhesion molecules in hearts with congestive and ischemic cardiomyopathy: immunohistochemical evaluation of inflammatory endothelial cell activation. Eur J Cardio-thorac Surg 27 (2005) 122-127
14. Conraads V.M., Bosmans J.M., Schuerwegh A.J., et al. Intracellular monocyte cytokine production and CD 14 expression are up-regulated in severe vs mild chronic heart failure. J Heart Lung Transplant 24 (2005) 854-859
15. Nathan C.F. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 80 (1987) 1550-1560
16. 2. Am J Physiol 256 (1989) H1012-H1022
17. Geppert A., Zorn G., Heinz G., Huber K., and Siostrzonek P. Soluble selectins in the pulmonary and systemic circulation in acute cardiogenic and non-cardiogenic pulmonary failure. Intensive Care Med 27 (2001) 521-527
18. Cotter G., Kaluski E., Moshkovitz Y., Milovanov O., Krakover R., and Vered Z. Pulmonary edema: new insight on pathogenesis and treatment. Curr Opin Cardiol 16 (2001) 159-163
19. Partridge C.A., Horvath C.J., Del Vecchio P.J., Phillips P.G., and Malik A.B. Influence of extracellular matrix in tumor necrosis factor-induced increase in endothelial permeability. Am J Physiol 263 (1992) L627-L633
20. Drexler H., Hayoz D., Munzel T., et al. Endothelial function in chronic congestive heart failure. Am J Cardiol 69 (1992) 1596-1601
21. Tentolouris C., Tousoulis D., Antoniades C., et al. Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. Int J Cardiol 94 (2004) 301-305
22. Ferrari R., Bachetti T., Agnoletti L., Comini L., and Curello S. Endothelial function and dysfunction in heart failure. Eur Heart J 19 suppl G (1998) G412-G447
23. Katz S.D. The role of endothelium-derived vasoactive substances in the pathophysiology of exercise intolerance in patients with congestive heart failure. Prog Cardiovasc Dis 38 (1995) 23-50
24. Berry C., and Clark A.L. Catabolism in chronic heart failure. Eur Heart J 21 (2000) 521-532
25. Tsutamoto T., Wada A., Maeda K., et al. Angiotensin II type I receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure. J Am Coll Cardiol 35 (2000) 714-721
26. Drexler H., Kurz S., Jeserich M., Munzel T., and Hornig B. Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure. Am J Cardiol 76 (1995) 13E-18E
27. Chen J.W., Lin F.Y., Chen Y.H., Wu T.C., Chen Y.L., and Lin S.J. Carvedilol inhibits TNF-α-induced endothelial transcription factor activation, adhesion molecule expression and adhesiveness to human mononuclear cells. Arterioscler Thromb Vasc Biol 24 (2004) 2075-2081
28. Nakamura K., Kusano K., Nakamura Y., et al. Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation 105 (2002) 2867-2871